Lawrence Steinman

Lawrence J.
Steinman is the founder of Nuon Therapeutics, Inc. (founded 2006), Neurocrine Biosciences, Inc. (founded 1997) where the title held is Director from 1997 to 2005, Bayhill Therapeutics, Inc. (founded 2001) where the title held is Director from 2010 to 2013, Atreca, Inc. (founded 2012) where the title held is Director from 2012 to 2019, Forum Markets, Inc. (founded 2013) where the title held is Director from 2024 to 2025, and Pasithea Therapeutics Corp.
(founded 2020) where the title held is Executive Chairman.
Dr. Steinman is also the founder of Drumroll Health, Inc.,Steinman Laboratory,Katexco Pharmaceuticals Corp.,Tolerion, Inc....
Current positions include Co-Chairman at CannBioRex Pharmaceuticals Corp.
since 2018, Co-Chairman at 180 Life Corp.
since 2019, Lead Independent Director at BioAtla, Inc. since 2020, Director at Himalaya Therapeutics, Member at National Academy of Sciences, Member at National Academy of Medicine (United States), Member-Supervisory Board at Pharnext SA since 2023, and Professor at Stanford University since 2011.
Former positions include Co-Executive Chairman at KBL Merger Corp.
IV, Chairman-Interdepartmental Program at Stanford University School of Medicine from 2003 to 2011, Director at Centocor, Inc. from 1990 to 1998, and Director at Neuronyx, Inc. Education includes an undergraduate degree from Dartmouth College conferred in 1968, a doctorate from Harvard Medical School conferred in 1973, a doctorate from Hasselt University conferred in 2008, and a doctorate from the University of Buenos Aires School of Medicine conferred in 2022.